Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03442582 · ClinicalTrials.gov registry record
Afluria Pregnancy Registry
A clinical trial, sponsored by Seqirus.
- Completed
- Registry status
- 490
- Enrollment target
NCT03442582: Completed study, sponsored by Seqirus.
NCT03442582 is a clinical trial that has completed, run by Seqirus. The registered enrollment target is 490 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03442582 has completed, sponsored by Seqirus.
- COMPLETED
- Registry status
- 490 participants
- Enrollment target
Study Summary
The study is a population based prospective cohort study designed to collect data on pregnancy outcomes and events of interest among women immunized with Afluria during pregnancy.
Primary Outcome
Pregnancy outcomes will be reported as one of the following: live birth, stillbirth, spontaneous abortion and elective termination
Interventions
- BIOLOGICAL Afluria Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 490 participants |
| Start Date | 2017-09-08 |
| Est. Completion | 2021-09-14 |
What the finished NCT03442582 record still lists
NCT03442582 is an observational study that tracks outcomes without assigning an intervention. The registered 490 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Afluria Influenza Vaccine is the first listed.
NCT03442582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03442582 about?
NCT03442582 is a clinical study titled "Afluria Pregnancy Registry". The study is a population based prospective cohort study designed to collect data on pregnancy outcomes and events of interest among women immunized with Afluria during pregnancy.
What is the current status of trial NCT03442582?
This trial is currently completed. The enrollment target is 490 participants. The study started on 2017-09-08. Estimated completion is 2021-09-14.
What interventions are being tested in trial NCT03442582?
The interventions under investigation include: Afluria Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT03442582?
This trial is sponsored by Seqirus, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04728893 · 490 participants · Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- NCT06238479 · 490 participants · Phase 1
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- NCT06336928 · 490 participants
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
- NCT06641414 · 490 participants · Phase 3
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI